Intent to Sole Source Specific Pathogen Free Fertile Eggs
Closed Special Notice Posted
- Solicitation number
- 75D301-26-Q-78762
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 112310 Chicken Egg Production
- PSC
- AJ13 General Science & Technology R&D Svcs; General Science & Technology; Experimental Development
- Place of performance
- Atlanta, Georgia 30345, United States
- Points of contact
-
- Dawnnia Daley xwf5@cdc.gov (404) 498-6079
- Liubov Kriel vyh1@cdc.gov (770) 488-2856
Notice details come from SAM.gov. Updated .
About this opportunity
The Department of Health and Human Services, through the Centers for Disease Control and Prevention's National Center for Immunization and Respiratory Diseases Influenza Division, has published a Special Notice announcing its intent to issue a sole source purchase order to Avian Vaccine Services LLC for Specific Pathogen Free (SPF) fertile chicken eggs. This sole source procurement is being conducted in accordance with FAR 13.106-1(b)(1) and will not be competitively solicited on SAM.gov. The notice is categorized under NAICS code 112310 (Chicken Egg Production) and falls within the General Science & Technology R&D Services procurement classification. The Special Notice was posted on November 19, 2025, with a deadline of December 4, 2025, for interested parties to submit responses.
The CDC intends to use the SPF eggs to produce research-grade eggs for the development of high-growth reassortant influenza candidate vaccine viruses and live attenuated influenza virus vaccine (LAIV) candidates, as well as for generating initial egg isolates from original clinical material. The government justifies the sole source award based on Avian Vaccine Services' proven track record in producing SPF eggs that have successfully supported candidate vaccine virus production and optimized laboratory protocols specific to the CDC's requirements. The notice emphasizes that genetic variations and microbiome differences among alternative suppliers could compromise isolation rates and jeopardize the Influenza Division's ability to deliver candidate vaccine viruses to manufacturers on schedule. While no competitive solicitation will be posted, the government encourages other firms capable of meeting the requirement to formally identify themselves and provide written correspondence detailing their qualifications and capability to supply compliant SPF eggs.
Notice text
The Center for Disease Control and Prevention (CDC), National Center for Immunization and Respiratory Diseases Influenza Division (NCIRD/ID), intends to award a sole source purchase order in accordance with FAR 13.106-1(b)(1), soliciting from a single source, to Avian Vaccine Services LLC, Address:1 Wisconsin Avenue, Suite 100, Norwich, CT 06360, for Specific Pathogen Free (SPF) Fertile Chicken Eggs. The purpose of this requirement is to furnish Research-Specific Pathogen-Free Eggs for the production of high-growth reassortant influenza candidate vaccine viruses and live attenuated influenza virus vaccine (LAIV) candidates, and generation of intial egg isolates from original clinical material.The NAICS code for this procurement is 112310, Chicken Egg Production.
The vaccine seed candidates must have the antigenic properties of the recommended strain and improved growth properties for more efficient vaccine production. SPF Eggs are produced under strictly isolated conditions to guarantee the absence of all disease agents and antibodies against specified agents, which are laid down in the European Pharmacopoecia and by the USDA. SPF Eggs from Avian Vaccine Services have resulted in the successful production of candidate vaccine viruses in the past and have optimized laboratory protocols. Genetics vary between the chicken flocks that supply SPF eggs. Additionally, variations of the microbiome among supplier flocks are expected. Obtaining genetically distinct SPF eggs from alternate suppliers may lead to changes in the isolation rate and potential quality of resulting isolates. This could risk the ability of the Influenza Division to provide candidate vaccine egg viruses to manufacturers in a timely manner.
As a result of this notice, no competitive solicitation will be posted on SAM.gov. The government will issue only one solicitation to Avian Vaccine Services. However, firms that believe they can meet this requirement are encouraged to identify themselves and give written notice by providing a capability statement to the contract specialist, Dawnnia Daley, at xwf5@cdc.gov by December 4, 2025, at 5:00 p.m. ET. The contract specialist will not respond to verbal requests. All requests must be in writing.
A determination by the government not to take this proposed action will be based on responses to this notice and is solely within the discretion of the contracting officer. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement. Inquiries shall reference the solicitation number, 75D301-26-Q-78762, on the subject line and be sent to Dawnnia Daley by email at xwf5@cdc.gov.
On GovTribe
Work this opportunity on GovTribe
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity